Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Surya

Showing results (21-30 of 5,785) with videos related to

Pageof 579
Sort By:
Chemical Biology & Drug Design|September 3, 2016
Analysis of residue conformations in peptides in Cambridge structural database and protein-peptide structural complexesUpadhyayula Surya Raghavender
Current Opinion in Pediatrics|December 12, 2018
Updates on progress in cancer screening for children with hereditary cancer predisposition syndromesSurya P Rednam
Current Medicinal Chemistry|September 26, 2022
Novel Proline Derivatives for Treating COVID-19Surya K De
Current Medicinal Chemistry|April 16, 2023
Futibatinib: A Potent and Irreversible Inhibitor of Fibroblast Growth Factor Receptors for Treatment of the Bile Duct CancerSurya K De
Current Medicinal Chemistry|May 5, 2023
Recent Discovery of Peptidomimetics for the Treatment of Coronavirus (COVID-19), Human Coronavirus, and EnterovirusesSurya K De
Current Medicinal Chemistry|May 1, 2023
Mitapivat: A Novel Treatment of Hemolytic Anemia in Adults with Pyruvate Kinase DeficiencySurya K De
Current Medicinal Chemistry|May 22, 2023
Discovery of Novel Cysteine Protease Inhibitors for the Treatment of Coronavirus (COVID-19)Surya K De
Current Medicinal Chemistry|February 21, 2023
Oteseconazole: First Approved Orally Bioavailable and Selective CYP51 Inhibitor for the Treatment of Patients with Recurrent Vulvovaginal CandidiasisSurya K De
Anti-Cancer Agents in Medicinal Chemistry|March 24, 2023
First Approval of Pacritinib as a Selective Janus Associated Kinase-2 Inhibitor for the Treatment of Patients with MyelofibrosisSurya K De
Recent Patents on Anti-Cancer Drug Discovery|February 28, 2023
New 1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-1-yl)ethyl)-2-phenylisoquinoline-1(2<i>H</i>)-ones as Phosphoinositide 3-kinase Inhibitors for Treating Cancer and Other DiseasesSurya K De
Pageof 579

Showing results (21-30 of 5,785) with videos related to

Sort By:
Pageof 579
Chemical Biology & Drug Design|September 3, 2016
Analysis of residue conformations in peptides in Cambridge structural database and protein-peptide structural complexesUpadhyayula Surya Raghavender
Current Opinion in Pediatrics|December 12, 2018
Updates on progress in cancer screening for children with hereditary cancer predisposition syndromesSurya P Rednam
Current Medicinal Chemistry|September 26, 2022
Novel Proline Derivatives for Treating COVID-19Surya K De
Current Medicinal Chemistry|April 16, 2023
Futibatinib: A Potent and Irreversible Inhibitor of Fibroblast Growth Factor Receptors for Treatment of the Bile Duct CancerSurya K De
Current Medicinal Chemistry|May 5, 2023
Recent Discovery of Peptidomimetics for the Treatment of Coronavirus (COVID-19), Human Coronavirus, and EnterovirusesSurya K De
Current Medicinal Chemistry|May 1, 2023
Mitapivat: A Novel Treatment of Hemolytic Anemia in Adults with Pyruvate Kinase DeficiencySurya K De
Current Medicinal Chemistry|May 22, 2023
Discovery of Novel Cysteine Protease Inhibitors for the Treatment of Coronavirus (COVID-19)Surya K De
Current Medicinal Chemistry|February 21, 2023
Oteseconazole: First Approved Orally Bioavailable and Selective CYP51 Inhibitor for the Treatment of Patients with Recurrent Vulvovaginal CandidiasisSurya K De
Anti-Cancer Agents in Medicinal Chemistry|March 24, 2023
First Approval of Pacritinib as a Selective Janus Associated Kinase-2 Inhibitor for the Treatment of Patients with MyelofibrosisSurya K De
Recent Patents on Anti-Cancer Drug Discovery|February 28, 2023
New 1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-1-yl)ethyl)-2-phenylisoquinoline-1(2<i>H</i>)-ones as Phosphoinositide 3-kinase Inhibitors for Treating Cancer and Other DiseasesSurya K De
Pageof 579